Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease

Amolika Dhungana, Serena Becchi, Jessica Leake, Gary Morris, Nesli Avgan, Bernard W. Balleine, Bryce Vissel and Laura A. Bradfield
eNeuro 17 January 2023, 10 (2) ENEURO.0363-22.2023; https://doi.org/10.1523/ENEURO.0363-22.2023
Amolika Dhungana
1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serena Becchi
3School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Leake
1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
3School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Morris
1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
4Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nesli Avgan
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard W. Balleine
5Decision Neuroscience Laboratory, School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernard W. Balleine
Bryce Vissel
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
6School of Clinical Medicine, University of New South Wales Medicine & Health, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura A. Bradfield
1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
2Centre for Neuroscience and Regenerative Medicine, St. Vincent’s Centre for Applied Medical Research, St. Vincent’s Health Network, Sydney, New South Wales 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura A. Bradfield
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Outcome devaluation performance was initially impaired in 36-week-old male J20 mice and in all 52-week-old mice regardless of genotype. A, Design of outcome devaluation. B, Lever press rates (±SEM) during days 1–4 of lever press acquisition. C, Lever press rates during the 4-d devaluation test. D, Lever press rates during the 4-d devaluation test displayed as a percentage of baseline responding. E, Magazine entries during the 4-d devaluation test. A = action, O = outcome. *p < .05, n.s. = non-significant.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Outcome devaluation was intact in the 8-d devaluation test for all male mice, regardless of age or genotype. A, Lever press rates (±SEM) during days 5–8 of lever press acquisition. B, Lever press rates during the 8-d devaluation test. C, Lever press rates during the 8-d devaluation test displayed as a percentage of baseline responding. D, Magazine entries during the 8-d test. *p < .05, n.s. = non-significant.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Outcome-selective reinstatement was impaired in 52-week-old J20 male mice but was unaltered in J20 male mice at 36 weeks old. A, Design of the outcome selective reinstatement procedure. B, Lever press rates during outcome selective reinstatement testing of 52 week olds. C, Lever press rates during the same test as a percentage of baseline responding. D, Lever press rates during outcome selective reinstatement testing of a separate cohort of 36 week olds. E, Lever press rates during the same test as a percentage of baseline responding. A = action, O = outcome. *p < .05, n.s. = non-significant.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Outcome devaluation performance is initially impaired in female J20 mice at 36 weeks old. A, Lever press rates (±SEM) during days 1–4 of acquisition. B, Lever press rates during the 4-d devaluation test. C, Lever press rates during the 4-d devaluation test displayed as a percentage of baseline responding. D, Magazine entries during the 4-d test. *p < .05, n.s. = non-significant.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Outcome devaluation performance was intact for all female mice, regardless of genotype, after 8 d of lever press training. A, Lever press rates (+/–) SEM during days 5–8 of acquisition. B, Lever press rates during the 8-d devaluation test. C, Lever press rates during the 8-d devaluation test as a percentage of baseline responding. D, Number of entries into the food receptacle (magazine) averaged over days 5–8. *p < .05, n.s. = non-significant.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Outcome-selective reinstatement was intact for all females, regardless of genotype. A, Lever press rates for female 36-week-old mice during outcome selective reinstatement testing. B, Lever press rates on the same test expressed as a percentage of baseline responding. *p < .05, n.s. = non-significant.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Quantification of IBA1 and Amylo Glo expression in the dorsal CA1 of male mice. A–D, Representative photomicrographs of male dorsal CA1 stained with Amylo Glo (red) in each group. Scale bar: 100 μm. A’–D’, Representative photomicrographs of male dorsal CA1 stained with Amylo Glo (red) and IBA1 (green) in each group. A’’–D’’, Enlarged inset. E, Number of cells positively immunostained for IBA1 per mm2. F, Number of plaques positively immunostained for Amylo Glo (taken from IBA1 images) per mm2. G, IBA1 intensity quantification. H, Correlation between IBA1 intensity and devaluation ratio from the 4-d test. I, Correlation between IBA1 intensity and devaluation ratio from the 8-d test. J, IBA1 intensity quantification for 36-week-old J20 males versus 36-week-old J20 females. *p < .05, n.s. = non-significant.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Quantification of GFAP and Amylo-Glo expression in the dorsal CA1 of male mice. A–D, Representative photomicrographs of male dorsal CA1 stained with Amylo Glo (red) in each group. Scale bar: 100 μm. A’–D’, Representative photomicrographs of male dorsal CA1 stained with Amylo Glo (red) and GFAP (green) in each group. A’’–D’’, Enlarged inset. E, Number of cells positively immunostained for GFAP per mm2. F, Number of plaques positively immunostained for Amylo-GLo (taken from GFAP images) per mm2. G, GFAP intensity quantification. H, GFAP intensity quantification, 36-week-old J20 males versus 36-week-old J20 females. *p < .05, n.s. = non-significant.

Back to top

In this issue

eneuro: 10 (2)
eNeuro
Vol. 10, Issue 2
February 2023
  • Table of Contents
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
Amolika Dhungana, Serena Becchi, Jessica Leake, Gary Morris, Nesli Avgan, Bernard W. Balleine, Bryce Vissel, Laura A. Bradfield
eNeuro 17 January 2023, 10 (2) ENEURO.0363-22.2023; DOI: 10.1523/ENEURO.0363-22.2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
Amolika Dhungana, Serena Becchi, Jessica Leake, Gary Morris, Nesli Avgan, Bernard W. Balleine, Bryce Vissel, Laura A. Bradfield
eNeuro 17 January 2023, 10 (2) ENEURO.0363-22.2023; DOI: 10.1523/ENEURO.0363-22.2023
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Alzheimer’s
  • decision-making
  • goal-directed action
  • hAPP-J20 mice
  • hippocampus
  • neuroinflammation

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Bidirectional Cerebellar Control of Supra-Second Timing in Rats
  • Fast spiking interneurons autonomously generate fast gamma oscillations in the medial entorhinal cortex with excitation strength tuning ING–PING transitions
  • The serotonin 1B receptor modulates striatal activity differentially based on behavioral context
Show more Research Article: New Research

Cognition and Behavior

  • Bidirectional Cerebellar Control of Supra-Second Timing in Rats
  • A Passage of Time Signal in the Human Brain
  • The serotonin 1B receptor modulates striatal activity differentially based on behavioral context
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.